InterMune, Inc. (ITMN) Misses Q2 EPS by 16c, Sees FY Revenue at High-End of Range

Go back to InterMune, Inc. (ITMN) Misses Q2 EPS by 16c, Sees FY Revenue at High-End of Range

InterMune (ITMN) PT Lifted at Baird as Esbriet Approval Appears Imminent

August 7, 2014 6:39 AM EDT

Baird analyst Brian Skorney reiterated a Outperform rating and boosted his price target on InterMune Inc. (NASDAQ: ITMN) to $50.00 (from $44.00) as Esbriet approval sounds imminent

Skorney comments, "Management's confidence in U.S. approval following regulatory discussions indicates that approval may be sooner than we... More